SIREN : 572028033
MERCK SANTE is a French company founded 69 years ago, specialized in the sector Fabrication de préparations pharmaceutiques. Based in LYON (69008), this company of category GE shows in 2023 a revenue of 625.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 625 179 606 € | 674 967 646 € | 608 334 338 € | 547 665 194 € | 490 233 887 € | 426 797 908 € | 411 873 514 € | 425 607 837 € |
| Net income | 35 923 139 € | 51 477 484 € | 68 506 896 € | 21 088 962 € | 36 541 441 € | 36 118 969 € | 41 097 208 € | 70 322 531 € |
| EBITDA | 81 030 212 € | 98 254 262 € | -22 543 566 € | -36 846 276 € | -29 183 203 € | -19 573 737 € | -13 750 776 € | 35 562 374 € |
| Net margin | 5.7% | 7.6% | 11.3% | 3.9% | 7.5% | 8.5% | 10.0% | 16.5% |
In 2023, MERCK SANTE achieves revenue of 625.2 M€. Over the period 2016-2023, the company shows strong growth with a CAGR (compound annual growth rate) of +5.6%. Slight decline of -7% vs 2022. After deducting consumption (186.7 M€), gross margin stands at 438.5 M€, i.e. a rate of 70%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 81.0 M€, representing 13.0% of revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 35.9 M€, i.e. 5.7% of revenue. This profit can be retained or distributed to shareholders.
625 179 606 €
438 453 740 €
81 030 212 €
64 502 959 €
35 923 139 €
13.0%
The debt ratio (= Financial debt / Equity x 100) stands at 26%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 51%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.9 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 8.5% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.
25.674%
51.33%
8.54%
0.923
36.6%
In 2023, the debt ratio of MERCK SANTE (25.67) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2023, the financial autonomy of MERCK SANTE (51.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2023, the repayment capacity of MERCK SANTE (0.92) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 160.91. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 6.3x. Operating income very largely covers interest expenses: high safety margin.
160.913
6.319
In 2023, the liquidity ratio of MERCK SANTE (160.91) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2023, the interest coverage of MERCK SANTE (6.3x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 12 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 15 days. Favorable situation: supplier credit is longer than customer credit by 3 days. Inventory turnover is 57 days (= Average inventory / Cost of goods x 360). Overall, WCR represents 31 days of revenue, i.e. 54.0 M€ to permanently finance. Over 2016-2023, WCR increased by +64%, requiring additional financing.
53 984 259 €
12 j
15 j
57 j
31 j
Indicative estimate only : the number of comparable transactions in this sector is limited (27 transactions). This range of 7 167 358€ to 22 029 657€ is provided for information purposes only and requires in-depth analysis to be confirmed.
This estimate is based on the analysis of 27 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare MERCK SANTE with other companies in the same sector:
Voir toutes les statistiques du secteur Fabrication de préparations pharmaceutiques
The revenue of MERCK SANTE in 2023 is 625.2 M€.
Yes, MERCK SANTE generated a net profit of 35.9 M€ in 2023.
The headquarters of MERCK SANTE is located in LYON (69008), in the department Rhone.
The tax return of MERCK SANTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
MERCK SANTE operates in the sector Fabrication de préparations pharmaceutiques (NAF code 21.20Z). See the 'Sector positioning' section above to compare the company with its competitors.